Healthcare Industry News: fractional flow reserve
News Release - July 8, 2008
RADI Medical Systems Launches Next Generation PressureWire(R) CertusUPPSALA, Sweden, July 8 (HSMN NewsFeed) -- RADI Medical Systems today announced improvements to their latest generation pressure sensing guide wire, PressureWireŽ Certus, which will begin shipments immediately.
The latest generation of the PressureWireŽ Certus features a new ergonomically designed proximal connector which provides three key advantages for physicians. The new large entry funnel allows for fast and easy wire reconnection into the proximal connector, while also exhibiting less insertion friction. In addition, the new locking cap provides positive reinforcement when the wire and the connector are locked in place via a user intuitive on and off twist function.
"The updated PressureWireŽ Certus is another step forward in ease of use," commented Nico Pijls, MD, Department of Cardiology at Catharina Hospital, Eindhoven, the Netherlands. "I am pleased that improvements to PressureWireŽ Certus occur frequently to assist in measuring FFR in more challenging anatomy, such as we faced in the recently completed FAME study (fractional flow reserve vs. Angiography for Multivessel Evaluation). In this multicenter randomized trial involving 1000 patients, FFR was measured in 3 arteries per patient using PressureWireŽ. Successful, unequivocally interpretable measurement could be achieved in 99.3% of all coronary arteries thanks to recent improvements to the PressureWireŽ."
The PressureWireŽ Certus is used in the assessment of fractional flow reserve (FFR). FFR expresses the maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of maximum blood flow in the absence of a stenosis. FFR is 100% specific in identifying which lesions are actually causing the flow restriction and may be treated.
"Radi continues to make improvements to the PressureWireŽ to improve product performance, and ultimately patient care," commented Jason Rudy, Director of Marketing of Radi Medical Systems, Inc. "This is a further improvement to PressureWireŽ Certus which has already received impressive physician performance feedback."
About Radi Medical Systems AB
Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The company's pioneering work in the field of interventional cardiology has resulted in market-leading intravascular sensors and hemostasis management and radiology devices. Radi works closely with medical practitioners to develop solutions that address clinical needs, as well as provide clinical education support. Founded in 1988, Radi employs more than 380 people globally and has representation in more than 40 countries. The company is based in Uppsala, Sweden, and maintains a U.S. headquarters in Wilmington, MA. For more information, visit http://www.radi.se.
Source: Radi Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.